ezetimibe has been researched along with nk 104 in 1 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (nk 104) | Trials (nk 104) | Recent Studies (post-2010) (nk 104) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 5 | 0 | 3 |
| Protein | Taxonomy | ezetimibe (IC50) | nk 104 (IC50) |
|---|---|---|---|
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 8.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, L; Chen, Z; Guo, S; Su, Y; Xie, L; Xu, D; Yin, M; Zeng, Z; Zhang, X; Zhou, H | 1 |
1 other study(ies) available for ezetimibe and nk 104
| Article | Year |
|---|---|
Virtual screening and experimental validation identify novel modulators of nuclear receptor RXRα from Drugbank database.
Topics: Crystallography, X-Ray; Databases, Factual; Drug Evaluation, Preclinical; Fatty Acids, Monounsaturated; Fluvastatin; Indoles; Ligands; Quinolines; Retinoid X Receptor alpha | 2017 |